44 results
8-K
EX-99.1
ALBT
Avalon GloboCare Corp
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
, greatly enhancing the solubility of designer peptides and proteins, therefore potentially expanding the repertoire of selected therapeutic targets … of the “cytokine storm” associated with COVID-19 and cellular immunotherapy delivery, as well as broadening the range of therapeutic targets addressable
8-K
8thx1j4 llxqrvd
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
PRE 14A
k2vr50jdir3a5hgz
29 Aug 23
Preliminary proxy
4:55pm
424B3
fjs5dsgtyxkd7f qaa
29 Jun 23
Prospectus supplement
4:31pm
8-K
EX-99.1
3utuculqvit9p3d
8 Nov 22
Entry into a Material Definitive Agreement
9:15am
8-K
EX-99.1
m7r3s4h
2 May 22
Regulation FD Disclosure
4:00pm
8-K
EX-99.1
pso xlfhk
4 Jan 22
Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical Programs
9:05am